UWC Education for Peace and Sustainability Officially Open by the Honourable Miss Alice Mak with student performances showcase the diversity of UWC
HONG KONG, Feb 3, 2023 – (ACN Newswire) – The United World College Hong Kong…
HONG KONG, Feb 3, 2023 – (ACN Newswire) – The United World College Hong Kong…
Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability…
Celyad Oncology has implemented a strategic shift from an organization focused on clinical development to…
NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (“Cellectis” or the “Company”) (Euronext…
Toronto, Ontario–(Newsfile Corp. – February 3, 2023) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
KUALA LUMPUR, Feb 3, 2023 – (ACN Newswire) – In conjunction with the Hari Wilayah…
JAKARTA, Feb 3, 2023 – (ACN Newswire) – The partnership of Hylobiz, a Vayana group…
SYDNEY, AU, Feb 3, 2023 – (ACN Newswire) – Novotech, the leading Asia Pacific focused…
PharmAla Biotech is the only company in the world with the ability to ship GMP…
WAYNE, Pa. and ROCKVILLE, Md., Feb. 02, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (NASDAQ: AVTX)…
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 02, 2023 (GLOBE NEWSWIRE) —…
Macky Kyle and his Greater Reach Marketing team help dentists and dental clinic owners leverage…
Patented Technology by SET is Gamechanger for Water and Gas AMI Endpoints CARLSBAD, Calif.–(BUSINESS WIRE)–#IoT–Smart…
SAN FRANCISCO and SHANGHAI, China, Feb. 02, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ:…
CHICAGO, Feb. 02, 2023 (GLOBE NEWSWIRE) — Wellspring, a global leader in software solutions for…
HONG KONG, Feb 3, 2023 – (ACN Newswire) – Hangzhou SF Intra-City Industrial Co., Ltd….
LONDON, Feb. 02, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced…
Significantly Refreshed Board Overseeing Successful Execution of Amarin’s Transformation Plan to Drive Short- and Long-Term…
SEATTLE, Feb. 02, 2023 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
4D-150 Phase 2 SPECTRA clinical trial for diabetic macular edema enrollment is expected to initiate…